Release Date: December 22, 2025
Expiration Date: December 22, 2026
Activity Overview
This Collaborating Across the Continuum® video-based program features 2 experts using a case-based approach to explore how mental health screening can be integrated into dermatology practice, recognizing the substantial psychological burden and elevated risk of suicidal ideation and behavior in individuals with psoriasis. Faculty review emerging evidence that biologic therapies may improve depressive symptoms by targeting shared inflammatory pathways, and provide practical guidance on screening, identifying red flags, and managing mental health crises. Designed to be engaging and clinically relevant, the program supports dermatology professionals in adopting best practices to improve outcomes for patients with psoriasis.
Target Audience
This educational activity is directed toward dermatologists, dermatology-focused NPs, dermatology-focused PAs, nurses, mental health professionals, and other HCPs involved in the management of patients with psoriasis.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Evaluate current evidence on the effects of biologic therapies for psoriasis on mental health
- Identify validated screening tools and red-flag indicators for detecting suicidal ideation and mental health crises in patients with psoriasis
- Integrate strategies to manage mental health crises into management plans in dermatology settings
John Koo, MD
Professor
University of California San Francisco Medical Center
Co-Director, UCSF Psoriasis Treatment Center
San Francisco, CA
Disclosures: Advisor, Consultant, Speaker, Honoraria Recipient: AbbVie, Amgen, Eli Lilly and Company, LEO Pharma, Pfizer, Regeneron Pharmaceuticals, Sanofi, Sun Pharma, UCB
T.J. Chao, MPAS, PA-C
Physician Assistant
Atlanta North Dermatology
Woodstock, GA
Disclosures: Advisor, Consultant, Speaker, Honoraria Recipient: AbbVie, Amgen, Arcutis Biotherapeutics, Botanix Pharmaceuticals, Bristol Myers Squibb, Eli Lilly and Company, Galderma, Incyte, Johnson & Johnson, Kowa Pharmaceuticals, LEO Pharma, Organon, Ortho Dermatologics, Regeneron Pharmaceuticals, Sanofi, Sun Pharma, UCB
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all conflicts of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here